2018 Peritonitis Drug Development- Pipeline Analysis Report

  • ID: 4527592
  • Report
  • 40 pages
  • VPA Research
10 % OFF
until Nov 30th 2018
1 of 4

FEATURED COMPANIES

  • BIOCND Inc
  • Galectin Therapeutics Inc
  • Novartis AG
  • Promethera Biosciences
  • TGV-Laboratories
  • Xfibra Inc
  • MORE
Inflammation of pertonitis, the lining of inner wall of abdomen is referred to as Peritonitis condition. It is an urgent medical condition and is highly infectious, with an estimated 10% mortality rates.

Over 15 companies and universities are focusing on developing treatment options for Peritonitis.

To assist investigators and funding and regulatory organizations, the publisher has come up with a comprehensive report on Peritonitis pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Peritonitis pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Peritonitis pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BIOCND Inc
  • Galectin Therapeutics Inc
  • Novartis AG
  • Promethera Biosciences
  • TGV-Laboratories
  • Xfibra Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2 Peritonitis Pipeline Analysis
2.1 Disease and Pipeline Overview
2.2 Peritonitis Pipeline Snapshot
2.3 Peritonitis Pipeline by Phase
2.4 Peritonitis Pipeline by Company
2.5 Peritonitis Pipeline by Mechanism of Action

3 Peritonitis- Company Wise Pipeline Analysis
  • Adenium Biotech
  • Atox Bio Ltd
  • Melinta Therapeutics
  • Reponex Pharmaceuticals
  • Sirtris
  • SynAct Pharma AB
  • Zytoprotec
4 Peritonitis R&D Pipeline Snapshots
Drug wise Pipeline Details
  • Therapeutic Candidate Name
  • Originator
  • Co-Developer/ License Partner
  • Orphan Drug Designation
  • Development Phase
  • Mechanism of Action
  • Current Status
  • Ongoing Clinical Trial Details
5 Recent Developments in Peritonitis Pipeline

6 Appendix
6.1 About the Publisher
6.2 Sources and Research Methodology

1.1 List of Figures
Figure 1: Peritonitis Pipeline by Phase, H1- 2018
Figure 2: Peritonitis Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Peritonitis Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018

1.2 List of Tables
Table 1: Peritonitis Pipeline by Phase, H1- 2018
Table 2: Peritonitis Pipeline by Companies, H1- 2018
Table 3: Peritonitis Pipeline by Mechanism of Action, H1- 2018
Table 4: Adenium Biotech Peritonitis pipeline, May 2018
Table 5: Atox Bio Ltd Peritonitis pipeline, May 2018
Table 6: Melinta Therapeutics Peritonitis pipeline, May 2018
Table 7: Reponex Pharmaceuticals Peritonitis pipeline, May 2018
Table 8: Sirtris Peritonitis pipeline, May 2018
Table 9: SynAct Pharma AB Peritonitis pipeline, May 2018
Table 10: Zytoprotec Peritonitis pipeline, May 2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bristol-Myers Squibb
  • BIOCND Inc
  • Elixirgen Therapeutics LLC
  • Galectin Therapeutics Inc
  • GWOXI Stem Cell Applied Technology
  • International Stem Cell Corporation
  • Mallinckrodt Pharmaceuticals
  • Nimbus Therapeutics
  • Novartis AG
  • Pharmicell Co Ltd
  • Promethera Biosciences
  • Rohto Pharmaceutical Co Ltd
  • Synlogic
  • TGV-Laboratories
  • VESSL Therapeutics Ltd
  • Xfibra Inc
  • XTuit Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll